71810-97-4Relevant articles and documents
Biosynthesis method and application of N-methyl-o-carborane-L-propionamide
-
Paragraph 0010; 0022-0027, (2021/04/17)
The invention discloses a biosynthesis method of N-methyl-o-carborane-L-propionamide, which comprises the following steps: 1, synthesizing L-propionamide by using D,L-alanine and ammonia water as raw materials and laccase as a catalyst, filtering the reaction product to remove the laccase, and introducing hydrogen chloride gas to generate L-propionamide hydrochloride; 2, in an organic solvent or ionic liquid, reacting with 1-bromomethyl-o-carborane under an alkaline condition to obtain the corresponding o-carborane derivative. According to the invention, through the degradation characteristics of laccase on amines and alcohols, it is accidentally found that laccase has the function of synthesizing the L-propylamine amide, and has the characteristics of high yield, safety, no pollution and the like. Therefore, by chemically synthesizing and modifying o-carborane and a relatively hydrophilic group L-propionamide, the purpose of increasing the polarity and cell affinity of the compound is achieved, so that the technical effect of targeted enrichment and high concentration of boron ions in tumor cells is achieved.
BICYCLIC COMPOUNDS
-
Paragraph 00725, (2020/06/01)
Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating cancers. Specific cancers include those that are mediated by YAP/TAZ or those that are modulated by the interaction between YAP/TAZ and TEAD.
HIV PROTEASE INHIBITORS
-
, (2008/06/13)
Peptide mimics, having a constrained peptide backbone conformation, are HIV protease inhibitors. A compound of this invention is, for example, 3-Benzyl-5(alaninyl-1-aminoethyl)-2,3,6,7-tetrahydro-N-azepinyl-2-propionyl-valinyl-valinyl methyl ester.